Dr. Nigel Beeley
Dr. Nigel Beeley has a successful 30-year track record of increasing responsibilities within the pharmaceutical, biotechnology, and renewable energy industries. He has a talent for quickly mastering technologies, understanding new sectors, and identifying key strategies and initiatives.
Dr. Beeley's interest in renewable energy spurred him to found ENRQI Inc., a startup company focused on Biofuels and renewable chemicals. More recently, he has become a partner and Chief Strategy Officer with Sinagy CleanTech, LLC., an energy related US/China business endeavor. During his career he has been involved in a number of projects that have delivered clinical candidates, four of which have become products.
His industrial career began at Reckitt and Coleman, Pharmaceuticals Division followed by eight years in the cardiovascular group of Synthélabo Recherche, Paris, France before returning to the UK in 1988 where he joined Celltech. In 1994, he became Senior Director of Chemistry at Amylin Pharmaceuticals, Inc. San Diego.
From early 1999 to June 2004 he was VP and Chief Chemical Officer at Arena Pharmaceuticals, Inc. where he built two substantial teams totaling over 120 chemically oriented scientists. From June 2004 to January 2007 he was VP, Discovery for Senomyx, Inc. Dr. Beeley was CEO, China Operations (Beijing) and a Consultant for BioDuro, Inc. from January 2007 until their acquisition by PPD in December 2009.
Dr. Beeley has co-authored over 70 scientific publications and abstracts and is co-inventor on over 90 patent applications, including over 40 issued US patents.
B.S. at University of Liverpool - Chemistry
M.S. and Ph.D. at University of Manchester
ETH, Zurich, Switzerland - Royal Society Overseas Research Fellow